share_log

HC Wainwright & Co. Maintains Buy on Arbutus Biopharma, Lowers Price Target to $5

Moomoo 24/7 ·  Mar 1 07:22

HC Wainwright & Co. analyst Ed Arce maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and lowers the price target from $6 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment